Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Antiviral Res. 2020 Jan 11;175:104712. doi: 10.1016/j.antiviral.2020.104712

Table 4.

Cytotoxicity evaluation of ALS-8112 in erythroid and myeloid bone marrow progenitor cells.

Compound CC50/CC90 (μM)
E-BM GM-BM
ALS-8112 4.0/11.4 3.7/8.8
AZT (positive control) 0.4/7.9 1.1/47.6

E-BM - erythroid bone marrow; GM-BM - granulocyte myeloid bone marrow.